Drug Profile
Research programme: Hedgehog cell-signalling pathway stimulants - MAX BioPharma
Alternative Names: Hedgehog signalling pathway activators - MAX BioPharma; Oxy 200; Oxy-133; Small molecule oxysterols - MAX BioPharmaLatest Information Update: 28 Aug 2021
Price :
$50
*
At a glance
- Originator MAX BioPharma
- Class Small molecules; Sterols
- Mechanism of Action Hedgehog cell signalling pathway stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Osteoporosis
Highest Development Phases
- No development reported Non-union fracture; Osteoporosis
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for preclinical development in Osteoporosis in USA (PO)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Non-union-fracture in USA
- 12 Jul 2017 Research programme: Hedgehog cell-signalling pathway stimulants - MAX BioPharma is available for licensing as of 10 Jul 2017. www.maxbiopharma.com